EUVIMEDEUVIMED entdecken
Crossref

Design, synthesis, and biological characterization of a hydrophobic tagging EGFR degrader for the treatment of non-small-cell lung cancer

Mo Li, Chengye Wang, Xingting Wang, Haotianyu Zhu, Yu Bai

Molecular Diversity · 16.07.2026 · 30 (6) · 10289-10302

DOI: 10.1007/s11030-026-11669-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Diversity, online erschienen am 16.07.2026. Verfasst von Mo Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, 116027, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Antineoplastic Agents, Drug Design. Die Arbeit nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

EGFR is a validated therapeutic target for non-small cell lung cancer (NSCLC). Herein, we designed and synthesized a series of gefitinib-based hydrophobic tagging (Hyt) degraders to induce EGFR degradation. Among them, B3 was identified as an active degrader, with DC50 values of 0.61 and 0.73 μM in the EGFR-del19 NSCLC cells HCC827 and PC9, respectively, and DT50 values of 9.2 and 13.7 h. Mechanistic studies showed that B3 accelerated EGFR turnover and revealed a degradation process involving the ubiquitin-proteasome system and the autophagy-lysosome pathway. B3 also suppressed EGFR downstream signaling and inhibited the proliferation of HCC827 and PC9 cells, with IC50 values of 0.17 and 0.25 μM, respectively. In an HCC827 xenograft model, B3 significantly inhibited tumor growth and reduced EGFR levels in tumor tissues without obvious toxicity. These results identify B3 as an active EGFR hydrophobic tag degrader and a useful compound for further investigation in NSCLC models harboring EGFR del19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsAntineoplastic AgentsDrug DesignProtein Kinase InhibitorsHumansErbB ReceptorsHydrophobic and Hydrophilic InteractionsAnimalsCell Line, TumorCell ProliferationProteolysisMiceXenograft Model Antitumor AssaysMice, Nude

Stichwörter der Autor:innen

EGFRHydrophobic taggingNon-small cell lung cancerTargeted protein degradation

Substanzen

ErbB ReceptorsAntineoplastic AgentsProtein Kinase InhibitorsEGFR protein, human

Autor:innen und Institutionen

  • Department of Thoracic Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, 116027, China.
  • Dalian Medical University, Dalian, 116027, China.
  • Department of Thoracic Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, 116027, China. baiyu@dmu.edu.cn.
  • Institute of Cancer Stem Cells, Dalian Medical University, Dalian, 116044, China. baiyu@dmu.edu.cn.

Zitieren

APA

Li, M., Wang, C., Wang, X., Zhu, H., & Bai, Y. (2026). Design, synthesis, and biological characterization of a hydrophobic tagging EGFR degrader for the treatment of non-small-cell lung cancer. Molecular Diversity, 30(6), 10289-10302. https://doi.org/10.1007/s11030-026-11669-1

Vancouver

Li M, Wang C, Wang X, Zhu H, Bai Y. Design, synthesis, and biological characterization of a hydrophobic tagging EGFR degrader for the treatment of non-small-cell lung cancer. Molecular Diversity. 2026;30(6):10289-10302. doi:10.1007/s11030-026-11669-1

BibTeX
@article{Li2026,
  author = {Li, Mo and Wang, Chengye and Wang, Xingting and Zhu, Haotianyu and Bai, Yu},
  title = {Design, synthesis, and biological characterization of a hydrophobic tagging EGFR degrader for the treatment of non-small-cell lung cancer},
  journal = {Molecular Diversity},
  year = {2026},
  volume = {30},
  number = {6},
  pages = {10289--10302},
  doi = {10.1007/s11030-026-11669-1}
}
Kostenlos starten →